Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib (Leukemia, (2022), 36, 5, (1253-1260), 10.1038/s41375-021-01496-8)

Research output: Contribution to journalComment/debatepeer-review

Abstract

We have noticed a minor error in figure 3. The number at risk of ponatinib group and dasatinib group were swapped. Below is the corrected figure.

Original languageEnglish (US)
Pages (from-to)1448
Number of pages1
JournalLeukemia
Volume36
Issue number5
DOIs
StatePublished - May 2022

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib (Leukemia, (2022), 36, 5, (1253-1260), 10.1038/s41375-021-01496-8)'. Together they form a unique fingerprint.

Cite this